Loading...
Loading...
Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Akorn Inc
AKRX is 51.57%. AKRX's revenue for the same period is $118.34 million.
The trailing-twelve-month profit margin at Hi-Tech Pharmacal Co Inc
HITK is 22.89%. HITK's ROE for the same period is 28.55%.
The trailing-twelve-month profit margin at Salix Pharmaceuticals Ltd
SLXP is 15.54%. SLXP's ROE for the same period is 18.41%.
The trailing-twelve-month profit margin at Medicis Pharmaceutical Corporation
MRX is 12.63%. MRX's PEG ratio is 1.15.
Trading Ideas.© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in